Daniel Sumarriva: Shaping the Future of Precision Oncology
Daniel Sumarriva, Executive Medical Director at SAGA Diagnostics, shared on LinkedIn:
“Last week, I had the privilege of onboarding our new Field Scientist MSL team at SAGA Diagnostics with an immersive visit to our RTP state-of-the-art lab operations.
Seeing the team connect, our top-tier technology and the spirit of cross-functional collaboration that drives our science was energizing and reinforced the very reason why I am at SAGA.
I couldn’t be prouder of the culture and talent we’ve brought together to the SAGA team. From WGS and ctDNA analysis to MRD innovation, this group represents the next wave of field medical and scientific affairs excellence, bridging cutting-edge Liquid Biopsy genomics to help advance Precision Oncology and make a real difference for patients with Pathlight.
Grateful for the opportunity to work alongside such talented colleagues and excited for what lies ahead.”
More posts featuring Daniel Sumarriva.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023